Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: Oxford Biomedica, (OXB).

05 Sep 2003 06:22 AM

27 Jun 2000 05:23 AM <--

Return to Oxford Biomedica, (OXB).

Oxford BioMedica is the UK's premier gene therapy company,
and is a major force in the global gene therapy scene. A
spin-out from the laboratory of Professors Alan and Sue
Kingsman in the Biochemistry department of Oxford
University, Oxford BioMedica was established in 1995 and
floated on the Alternative Investment Market of the London
Stock Exchange in December 1996.